_gilead-ceo-on-treating-covid-19-39we39re-not-finished-with-remdesivir39-preview-1.jpg "Gilead CEO on treating Covid-19: 'We're not finished with remdesivir' from immunomedics acquisition Video Screenshot Preview 1")
Gallery_gilead-ceo-on-treating-covid-19-39we39re-not-finished-with-remdesivir39-preview-3.jpg "Gilead CEO on treating Covid-19: 'We're not finished with remdesivir' from immunomedics acquisition Video Screenshot Preview 3")
Gallery_gilead-ceo-on-treating-covid-19-39we39re-not-finished-with-remdesivir39-preview-hqdefault.jpg "Gilead CEO on treating Covid-19: 'We're not finished with remdesivir' from immunomedics acquisition Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 3 minutes 54 seconds
👁 View: 2K times
Play Audio:👁 View: 2K times
Description:
CNBC Television
CNBC Television
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_the-outlook-for-therapeutics-and-vaccine-stocks.webp "CNBC Television")
_trump-media-amp-technology-group-posts-net-loss-in-first-quarter-as-the-truth-social-parent-company-pursues-mergers-stre.webp "Trump Media & Technology Group, the parent company of Donald Trump's Truth Social network, reported a net loss of over $300 million and total revenue of more than $770,000 in its first fiscal quarter. DJT shares were relatively flat in post-market trading following the earnings report's release. TMTG also said it signed contracts with a data center partner and hardware vendor to launch Truth Social's TV streaming platform in three phases. CEO Devin Nunes said the company is exploring potential mergers and acquisitions to expand Truth Social and develop its own content delivery network for the TV streaming platform.")
_gild-stock-124-gilead-sciences-acquires-immunomedics.webp "AlphaStreet")
_these-are-the-stocks-to-buy-for-the-next-10-years.webp "Fox Business")
_miracle-cancer-drug-trodelvy-changing-lives-at-it39s-put-on-the-pharmaceutical-benefits-scheme.webp "The Project")
⏲ 5 minutes 6 seconds 👁 2.2K
_gilead-ceo-daniel-o39day-on-remdesivir-pricing-and-ensuring-access-to-treatment.webp "CNBC Television")
⏲ 5 minutes 52 seconds 👁 11.5K
_deciphering-immuno-oncology-targeting-innate-immunity-in-cancer.webp "Cell Signaling Technology, Inc.")
_treasury-secretary-steven-mnuchin-on-talks-for-more-coronavirus-stimulus.webp "CNBC Television")
⏲ 4 minutes 18 seconds 👁 92.3K
_the-outlook-for-therapeutics-and-vaccine-stocks.jpg)
_trump-media-amp-technology-group-posts-net-loss-in-first-quarter-as-the-truth-social-parent-company-pursues-mergers-stre.jpg)
_gild-stock-124-gilead-sciences-acquires-immunomedics.jpg)
_these-are-the-stocks-to-buy-for-the-next-10-years.jpg)
_miracle-cancer-drug-trodelvy-changing-lives-at-it39s-put-on-the-pharmaceutical-benefits-scheme.jpg)
_gilead-ceo-daniel-o39day-on-remdesivir-pricing-and-ensuring-access-to-treatment.jpg)
_deciphering-immuno-oncology-targeting-innate-immunity-in-cancer.jpg)
_treasury-secretary-steven-mnuchin-on-talks-for-more-coronavirus-stimulus.jpg)
![[+]](/images/menu.gif){kind=small}